Cognitive improvement via cortical cannabinoid receptors and choline‐containing lipids
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.17381 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Marta Moreno-Rodríguez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain. Hauptthemen laut MEDLINE: Receptors, Cannabinoid, Choline. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III through the project (co-funded by European Regional Development Fund "A way to make Europe"), regional Basque Government to the "Neurochemistry and Neurodegeneration" consolidated research group, BIOEF project funded by Eitb Maratoia.
Abstract (Originalsprache)
Background and Purpose Recent research linking choline‐containing lipids to degeneration of basal forebrain cholinergic neurons in neuropathological states illustrates the challenge of balancing lipid integrity with optimal acetylcholine levels, essential for memory preservation. The endocannabinoid system influences learning and memory processes regulated by cholinergic neurotransmission. Therefore, we hypothesised that activation of the endocannabinoid system may confer neuroprotection against cholinergic degeneration. Experimental Approach We examined the neuroprotective potential of sub‐chronic treatments with the cannabinoid agonist WIN55,212‐2, using ex vivo organotypic tissue cultures including nucleus basalis magnocellularis and cortex and in vivo rat models of specific cholinergic damage induced by 192IgG‐saporin. Levels of lipids, choline and acetylcholine were measured with histochemical and immunofluorescence assays, along with [ 35 S]GTPγS autoradiography of cannabinoid and muscarinic GPCRs and MALDI‐mass spectrometry imaging analysis. Learning and memory were assessed by the Barnes maze and the novel object recognition test in rats and in the 3xTg‐AD mouse model. Key Results Degeneration, induced by 192IgG‐saporin, of baso‐cortical cholinergic pathways resulted in memory deficits and decreased cortical levels of lysophosphatidylcholines (LPC). WIN55,212‐2 restored cortical cholinergic transmission and LPC levels via activation of cannabinoid receptors. This activation altered cortical lipid homeostasis mainly by reducing sphingomyelins in lesioned animals. These modifications were crucial for memory recovery. Conclusion and Implications We hypothesise that WIN55,212‐2 facilitates an alternative choline source by breaking down sphingomyelins, leading to elevated cortical acetylcholine levels and LPCs. These results imply that altering choline‐containing lipids via activation of cannabinoid receptors presents a promising therapeutic approach for dementia linked to cholinergic dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain.
- Department of Psychiatry and Forensic Medicine, School of Medicine & Institute of Neuroscience, Autonomous University of Barcelona (UAB), Barcelona, Spain.
- Neurodegenerative Diseases, BioBizkaia Health Research Institute, Barakaldo, Spain.
ORCID-Profile: Marta Moreno-Rodríguez, Jonatan Martínez-Gardeazabal, Iker Bengoetxea de Tena, Alberto Llorente-Ovejero, Estibaliz González de San Román, Iván Manuel, Rafael Rodríguez-Puertas
Förderung
- Instituto de Salud Carlos III through the project (co-funded by European Regional Development Fund "A way to make Europe")
- regional Basque Government to the "Neurochemistry and Neurodegeneration" consolidated research group
- BIOEF project funded by Eitb Maratoia
Zitieren
APA
Moreno-Rodríguez, M., Martínez-Gardeazabal, J., Bengoetxea de Tena, I., Llorente-Ovejero, A., Lombardero, L., González de San Román, E., Giménez-Llort, L., Manuel, I., & Rodríguez-Puertas, R. (2025). Cognitive improvement via cortical cannabinoid receptors and choline‐containing lipids. British Journal of Pharmacology. https://doi.org/10.1111/bph.17381
Vancouver
Moreno-Rodríguez M, Martínez-Gardeazabal J, Bengoetxea de Tena I, Llorente-Ovejero A, Lombardero L, González de San Román E, et al. Cognitive improvement via cortical cannabinoid receptors and choline‐containing lipids. British Journal of Pharmacology. 2025. doi:10.1111/bph.17381
BibTeX
@article{MorenoRodrguez2025,
author = {Moreno-Rodríguez, Marta and Martínez-Gardeazabal, Jonatan and Bengoetxea de Tena, Iker and Llorente-Ovejero, Alberto and Lombardero, Laura and González de San Román, Estibaliz and Giménez-Llort, Lydia and Manuel, Iván and Rodríguez-Puertas, Rafael},
title = {Cognitive improvement via cortical cannabinoid receptors and choline‐containing lipids},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.17381}
}
EUVIMED